Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.45p
   
  • Change Today:
      0.000p
  • 52 Week High: 14.13
  • 52 Week Low: 3.40
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 1,543,329
  • Market Cap: £4.57m
  • RiskGrade: 435

Valirx Overview

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 1.2  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Valirx Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 n/a (4.83) (117.50)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (2.72) (4,135.00)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (1.54) (3.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (1.68) (2.34)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (2.60) (3.06)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Valirx Company Announcements

Evaluation Agreement with Imperial College London 21-Mar-2024 07:00 RNS
Board Re-structuring and update on requisition 19-Mar-2024 07:00 RNS
Shareholder Requisition Notice 04-Mar-2024 17:47 RNS

Valirx ShareCast News

ValiRx inks deal with Dundee Drug Discovery Unit 12-Feb-2024 ShareCast
ValiRx enters option deal with Ambrose Healthcare 05-Dec-2023 ShareCast
ValiRx enters partnership with StingRay Bio 10-Nov-2023 ShareCast

Valirx Top Newspaper Links

Business Digest 24-Sep-2006 Sunday Times

Latest Valirx Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Valirx Market Data

Currency UK Pounds
Share Price 3.45p
Change Today 0.000p
% Change 0.00 %
52 Week High 14.13
52 Week Low 3.40
Volume 1,543,329
Shares Issued 132.35m
Market Cap £4.57m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.79% below the market average20.79% below the market average20.79% below the market average20.79% below the market average20.79% below the market average
1.89% above the sector average1.89% above the sector average1.89% above the sector average1.89% above the sector average1.89% above the sector average
Price Trend
94.27% below the market average94.27% below the market average94.27% below the market average94.27% below the market average94.27% below the market average
85.96% below the sector average85.96% below the sector average85.96% below the sector average85.96% below the sector average85.96% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
15:35 42 @ 3.50p
11:46 5,000 @ 3.45p
10:47 588,265 @ 3.40p
10:48 586,622 @ 3.41p
10:05 10,000 @ 3.45p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page